J45
Asthma
Asthma is a chronic inflammatory disorder of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. The underlying pathophysiology involves a complex interplay between airway inflammation, intermittent airflow obstruction, and bronchial hyperresponsiveness. In susceptible individuals, this inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early morning. These episodes are usually associated with widespread but variable airflow obstruction that is often reversible either spontaneously or with treatment. The 2026 clinical guidelines emphasize the distinction between various phenotypes such as allergic (atopic) asthma, non-allergic asthma, adult-onset asthma, and asthma with persistent airflow limitation.
Clinical Symptoms
- Expiratory wheezing
- Shortness of breath (dyspnea)
- Chest tightness
- Paroxysmal cough, often worse at night or early morning
- Increased mucus production
- Decreased exercise tolerance
- Use of accessory muscles of respiration during exacerbations
- Tachypnea
- Prolonged expiratory phase
- Sleep disturbance due to respiratory distress
Common Causes
- Genetic predisposition and family history of atopy
- Environmental allergens (e.g., house dust mites, pollen, animal dander, mold)
- Respiratory viral infections (e.g., Rhinovirus, Respiratory Syncytial Virus)
- Occupational exposures (e.g., chemical fumes, wood dust, flour)
- Environmental tobacco smoke exposure (secondhand smoke)
- Air pollution (e.g., ozone, nitrogen dioxide, particulate matter)
- Physical exertion or exercise-induced bronchoconstriction
- Cold air or sudden changes in weather
- Strong emotions or stress inducing hyperventilation
- Gastroesophageal reflux disease (GERD)
Documentation & Coding Tips
Distinguish between persistence levels and episode types clearly to capture correct code specificity.
Example: Assessment: 34-year-old female with moderate persistent asthma, currently presenting with an acute exacerbation. Symptoms include increased cough and shortness of breath for 48 hours. FEV1 is 68 percent of predicted. Billing Focus: Code J45.41 for moderate persistent asthma with acute exacerbation. Risk Adjustment: Maps to HCC 112, reflecting moderate severity and resource intensity.
Billing Focus: Identify persistence (mild, moderate, severe) and episode (uncomplicated, exacerbation, status asthmaticus).
Document the presence of status asthmaticus when the patient fails to respond to initial bronchodilator therapy.
Example: Impression: 12-year-old male with severe persistent asthma in status asthmaticus. Patient failed to respond to three consecutive albuterol nebulizer treatments and remains in respiratory distress with accessory muscle use. Billing Focus: Code J45.52 for severe persistent asthma with status asthmaticus. Risk Adjustment: Status asthmaticus indicates a high-acuity event with significantly increased clinical risk.
Billing Focus: Verification of non-responsiveness to initial rescue therapy is key for status asthmaticus.
Link environmental and occupational triggers when they are the primary cause of the asthma symptoms.
Example: Assessment: Occupational asthma due to exposure to wood dust at cabinetry shop. Patient experiences wheezing and chest tightness primarily during work hours, improving on weekends. Billing Focus: Code J45.998 for other asthma, which includes allergic and occupational types. Risk Adjustment: Captures the external etiology of the chronic condition.
Billing Focus: Documentation of the specific allergen or irritant is necessary for coding secondary codes like Z57.39.
Specify the role of comorbid conditions such as allergic rhinitis or chronic sinusitis in managing asthma.
Example: Plan: Patient has mild persistent asthma with seasonal allergic rhinitis. Rhinitis is poorly controlled and contributing to nighttime asthma awakenings. Starting intranasal corticosteroids and continuing daily ICS-LABA. Billing Focus: J45.30 for asthma and J30.1 for allergic rhinitis. Risk Adjustment: Comorbidities increase the medical decision making (MDM) level for E/M coding.
Billing Focus: Captures the interaction between comorbid conditions to support higher level MDM.
Incorporate FEV1 measurements and frequency of rescue inhaler use to validate documented severity.
Example: Note: Patient exhibits mild intermittent asthma, uncomplicated. Use of SABA is less than 2 days per week. No nighttime awakenings. FEV1 is 82 percent. Billing Focus: J45.20. Risk Adjustment: This is a non-HCC code but provides a baseline for future progression to higher risk categories.
Billing Focus: Numerical data such as FEV1 and symptom frequency support the specific ICD-10 category selected.
Relevant CPT Codes
-
99213 - Office or other outpatient visit for the evaluation and management of an established patient, low MDM, 20-29 minutes
Typically used for routine follow-ups of well-controlled mild or moderate asthma where only minor medication adjustments occur.
-
99214 - Office or other outpatient visit for the evaluation and management of an established patient, moderate MDM, 30-39 minutes
Common for asthma exacerbations or when management includes complex medication changes such as starting biologics.
-
94010 - Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation
Essential for diagnosing asthma and determining the severity level of persistence.
-
94060 - Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration
Demonstrates the reversibility of airway obstruction, a hallmark of asthma diagnosis.
-
94640 - Pressurized or nonpressurized inhalation treatment for acute airway obstruction
Commonly performed in office or ER settings for acute asthma exacerbations.
-
95004 - Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report
Identifies external triggers for allergic asthma to guide avoidance and immunotherapy.
-
99204 - Office or other outpatient visit for the evaluation and management of a new patient, moderate MDM, 45-59 minutes
Standard for new patient evaluations of asthma where a full history, exam, and treatment plan are established.
-
94726 - Plethysmography for determination of lung volumes and, when performed, airway resistance
Used in complex cases where air trapping or restrictive components are suspected alongside asthma.
-
96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
Required for the administration of certain monoclonal antibodies for severe eosinophilic asthma.
-
99215 - Office or other outpatient visit for the evaluation and management of an established patient, high MDM, 40-54 minutes
Used for unstable patients with severe persistent asthma or those experiencing life-threatening exacerbations.
Related Diagnoses
- J45.20 - Mild intermittent asthma, uncomplicated
- J45.31 - Mild persistent asthma with (acute) exacerbation
- J45.42 - Moderate persistent asthma with status asthmaticus
- J45.50 - Severe persistent asthma, uncomplicated
- J45.901 - Unspecified asthma with (acute) exacerbation
- J44.9 - Chronic obstructive pulmonary disease, unspecified
- J30.1 - Allergic rhinitis due to pollen
- J45.991 - Cough variant asthma
- J45.990 - Exercise induced bronchospasm
- J45.998 - Other asthma